Google
×
Rhythm Pharmaceuticals

Rhythm Pharmaceuticals

Firma biotechnologiczna
Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare ...
Więcej pytań
We're dedicated to transforming the lives of patients and their families living with hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) ...
Rhythm Pharmaceuticals Inc / Cena akcji
43,16 +1,37 (3,28%)
RYTM(NASDAQ)
28 mar, 12:08 PM GMT-4 · Waluta: USD · Wyłączenie odpowiedzialności
Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development and commercialization of peptide therapeutics for the treatment ...
Eight voice analog drum computer & sampler. Layer distinctive analog percussion with digital samples. Bring in the power of sequencing and performance controls.
Rhythm Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company. The Company is focused on advancing its melanocortin-4 receptor (MC4R) ...
NASDAQ: RYTM. $39.68 0 (0.00%). Data Provided by Refinitiv. Minimum 15 minutes ... Rhythm's stock is traded on the NASDAQ Global Market under the symbol RYTM.
RYTM | Complete Rhythm Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Ocena (8)
The average price target for Rhythm Pharmaceuticals Inc is $56.25. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
Rhythm Pharmaceuticals Inc (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapies for the treatment of rare ...
Rhythm Pharmaceuticals, Inc.'s stock symbol is RYTM and currently trades under NASDAQ. It's current price per share is approximately $39.65.